Publication | Open Access

Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer

OncologyMedicineImmune Checkpoint InhibitorBreast CancerPharmacotherapyAnti-cancer AgentIkkε/tbk-1 AxisPharmacological InhibitionCancer TreatmentPharmacologyCell BiologyTumor Biology